A jarring new study has revealed that Parkinson’s disease cases worldwide are on track to more than double over the next three decades, highlighting an urgent need for greater awareness and earlier ...

A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...

Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues. For people with autoimmune disease, T cell reactivity is a big ...

A simple blood test may help identify people at the earliest stages of Parkinson’s disease, long before they begin to show symptoms, new research has found. The study, published on Friday in the ...

A technique that uses videos and machine learning to quantify motor symptoms in early-stage Parkinson’s disease could help reveal signs of the disease and other movement disorders earlier, which could ...

Ventyx Biosciences announced positive results from its Phase 2a study of VTX3232, an NLRP3 inhibitor, demonstrating safety and tolerability in patients with early-stage Parkinson's disease. The study ...

Exercise in general can help patients manage symptoms, but without head-to-head trials, the ‘best’ exercise is the one the patient can do well and will stick with, experts say.

Parkinson's disease affects more than 1.1 million people in the United States, progressively damaging the brain cells that control movement. By the time symptoms like tremors appear, patients have ...

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...